Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 4 Trials for Azithromycin (DB00207)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05299567Efficacy and Safety of Azithromycin in Patients With Bronchiolitis ObliteransTreatment
NCT01009619Azithromycin in Bronchiolitis Obliterans SyndromePrevention